Publications by authors named "Tyldesley Scott"

Claim this Profile
M
Multinational validation of distant metastasis velocity as a post-progression prognostic score in patients with oligometastatic cancer treated with metastasis-directed stereotactic body radiotherapy.
Jonas Willmann, Sarah Baker, Hanbo Chen, Edward Christopher Dee, Eugenia Vlaskou Badra, Scott Tyldesley

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trial.
Tamim Niazi, Fred Saad, Steven Tisseverasinghe, Rashmi Koul, Isabelle Thibault, Scott Tyldesley

Lancet Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of clinical target volume utilization on outcomes in patients with non-spine bone oligometastases treated with stereotactic ablative radiation therapy.
Emily O'Reilly, Eshawn Johal, Haley Clark, Benjamin Mou, Reno Eufemon Cereno, Scott Tyldesley

Radiother Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial.
Aiden Kooyman, Jee Suk Chang, Mitchell Liu, Will Jiang, Alanah Bergman, Scott Tyldesley

Int J Radiat Oncol Biol Phys· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial.
Sarah Baker, Curtis Leclerc, Hanna Atmanspacher-Wirth, Yizhou Zhao, Devin Schellenberg, Scott Tyldesley

Int J Radiat Oncol Biol Phys· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of a negative PSMA PET/CT in biochemical recurrence of prostate cancer.
Sara Harsini, Patrick Martineau, Sonia Plaha, Heather Saprunoff, Catherine Chen, Scott Tyldesley

Cancer Imaging· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy.
Marie-Pier St-Laurent, George Acland, Sarah N Hamilton, Jeremy Hamm, Katherine Sunderland, Scott Tyldesley

J Urol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Author.
Marie-Pier St-Laurent, George Acland, Sarah N Hamilton, Jeremy Hamm, Katherine Sunderland, Scott Tyldesley

J Urol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of access-driven Canadian treatment sequences in progressive prostate cancer (REACTIVATE).
Jenny J Ko, Lawrence Mbuagbaw, Scott Tyldesley, Jennifer Lowther, Katherine Sunderland

Can Urol Assoc J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.
Sarah Baker, Linden Lechner, Mitchell Liu, Jee Suk Chang, Ella Mae Cruz-Lim, Scott Tyldesley

Int J Radiat Oncol Biol Phys· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case - Laparoscopic radical prostatectomy in a transgender woman after gender-affirming vaginoplasty.
Sahil Kumar, Scott Tyldesley, Christina I Poon, James T W Saunders, Christopher C Hoag

Can Urol Assoc J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of access-driven Canadian treatment sequences in progressive prostate cancer (REACTIVATE).
Jenny J Ko, Lawrence Mbuagbaw, Scott Tyldesley, Jennifer Lowther, Katherine Sunderland

Can Urol Assoc J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linear accelerator maintenance cost analysis.
Marco Carlone, Wayne Beckham, Cheryl Duzenli, Kirpal Kohli, Scott Tyldesley

J Appl Clin Med Phys· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.
Robert Olson, Hadassah Abraham, Curtis Leclerc, Alexander Benny, Sarah Baker, Scott Tyldesley

BMC Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial.
Reno Eufemon Cereno, Benjamin Mou, Sarah Baker, Nick Chng, Gregory Arbour, Scott Tyldesley

Radiother Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Updated Analysis of the Survival Endpoints of ASCENDE-RT.
Justin Oh, Scott Tyldesley, Howard Pai, Michael McKenzie, Ross Halperin

Int J Radiat Oncol Biol Phys· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy.
Sara Harsini, Don Wilson, Heather Saprunoff, Hayley Allan, Martin Gleave, Scott Tyldesley

Cancer Imaging· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial.
Sarah Baker, Benjamin Mou, Will Jiang, Mitchell Liu, Alanah M Bergman, Scott Tyldesley

Int J Radiat Oncol Biol Phys· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial.
Sarah Baker, Will Jiang, Benjamin Mou, Chad R Lund, Mitchell Liu, Scott Tyldesley

Int J Radiat Oncol Biol Phys· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.
Robert Olson, Will Jiang, Mitchell Liu, Alanah Bergman, Devin Schellenberg, Scott Tyldesley

JAMA Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-Canadian consensus recommendations for proton beam therapy access in Canada.
Gunita Mitera, Derek Tsang, Boyd McCurdy, Karen Goddard, Annie Ebacher, Scott Tyldesley

Radiother Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysis.
Justin Oh, W James Morris, Ingrid Spadinger, Scott Tyldesley, Mira Keyes

Brachytherapy· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.
Robert J Hamilton, Christina Canil, Noa Shani Shrem, Kopika Kuhathaas, Maria Di Jiang, Scott North, Scott Tyldesley

Can Urol Assoc J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small cell carcinoma of the bladder: A population-based analysis of long-term outcomes after radical cystectomy and bladder conservation with chemoradiotherapy.
Justin Oh, Bernhard Eigl, Peter C Black, Tom Pickles, Carlos Villamil, Scott Tyldesley

Can Urol Assoc J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care.
Adam J N Raymakers, David Cameron, Scott Tyldesley, Dean A Regier

Curr Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis